Charles River Laboratories International
CRL
NYSE
IPO2000
about CRL
Charles River Laboratories International provides biopharmaceutical testing services, including preclinical research, analytical testing, and regulatory consulting, supporting drug development and compliance for global healthcare companies.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $157.55 | $157.97 | $152.18 | $7.97B | 762.78K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$1.06 | 33.24 | 7.35 | 9.70% | 5.11% | 0% |